Prof Howard Gurney

Professor Howard Gurney is the Director of Clinical Trials and Head of Medical Oncology for the Faculty of Medicine and Health Sciences at Macquarie University and Senior Staff Specialist in Medical Oncology at Westmead Hospital.

Dr Gurney has a strong background in clinical research and has subspecialty interests in urogenital cancers, including prostate, bladder, testis, and kidney cancer.

He has been the principal investigator for over 150 clinical trials and has over 150 peer-reviewed publications in genitourinary cancers and pharmacogenomics, including recent papers in the New Engl J Med, Lancet, and Lancet Oncology, with an H-index of 52. His publications have over 18,000 citations and over 15,000 in the last five years. His current research interests include pharmacogenomics and therapeutic monitoring of chemotherapy and targeted therapies, and he has published widely in this area. He is regarded as an authority on mechanisms for safe dosing of anticancer agents, has held research grants, and has written several invited editorials on these topics.

Macquarie University Hospital
Norwest Private Hospital
Westmead Public Hospital

Clinical Trials in Oncology